Rise of generics and patent expirations sees CPhI and P-MEC India 2013 expand
Event to be held at the Bombay Convention and Exhibition Centre, from December 3 to 5, 2013
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Jubilant Life Sciences receives ANDA approval for Quetiapine Fumarate tablets
Is indicated for the treatment of schizophrenia, and for the treatment of acute manic episodes associated with bipolar disorder
Cadila Pharmaceuticals and UK’s Helperby Therapeutics in pact
To invest in R&D for development of antibiotic resistance breakers
OPPI Conclave focuses on attracting young talent to the pharmaceutical industry
Event saw industry stalwarts, multinational pharma companies, distinguished academicians and HR leaders from the pharma and allied…
Bone Therapeutics initiates a phase IIb/III trial
Receives approval from Competent Authorities in Belgium, France and the Netherlands
IPA suggests ban on B.Sc. (Community Health) programme
Takes up issue with Registrar, Pharmacy Council of India
Sanofi India partners with PVR Nest
Healthy Children, happy children’ initiative will jointly reach out to 2,00,000 children
Genomic Health and Almac Group enter exclusive in-licensing agreement
To develop and commercialise Anthracycline Chemotherapy benefit test for high risk breast cancer
Biocon & Mylan receive Indian regulatory approval for Biosimilar Trastuzumab
Will help in the treatment of Her 2+ metastatic breast cancer